Retraction
A novel, orally active alpha 4 integrin antagonist, AJM300 prevents the development of experimental colitis induced by adoptive transfer of IL-10 deficient CD4(+) T cells in mice
Paper Information
Record ID:
3938
Author(s):
Journal:
Publication Date:
July 03, 2012
Retraction Date:
August 14, 2012
(13.3 years years ago)
Subjects:
Institutions:
Country:
🇯🇵 JapanArticle Type:
Publisher:
ASPET: American Society for Pharmacology and Experimental Therapeutics
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1124/jpet.112.193946Additional Notes:
affiliations taken from related articles by authors
Citations (3)
3
Total Citations3
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
1263
Days since retraction (latest)
Paper citing A novel, orally active alpha 4 integrin antagonist...
Unknown Authors
Unknown Journal
Published: Jan 2016
1263 days after retraction
Paper citing A novel, orally active alpha 4 integrin antagonist...
Unknown Authors
Unknown Journal
Published: Oct 2012
62 days after retraction
Paper citing A novel, orally active alpha 4 integrin antagonist...
Unknown Authors
Unknown Journal
Published: Oct 2012
61 days after retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
13.3 years
Open Access:
Yes
Last Checked:
Never